GoKawiilPostEra, a YC-backed biotech, opens AI researcher roles for drug discovery
PostEra, a Y Combinator-backed biotech company, is hiring AI researchers to expand its agentic research team. The company uses its Proton platform to speed up medicinal chemistry work, has nominated multiple clinical candidates in women's health and fertility, and has secured over $1 billion in AI partnerships with firms including Pfizer and Amgen. It also runs an antiviral drug discovery center backed by a major NIH grant.
GoKawiil's interpretation of the reporting above, not reported fact.
The hiring push signals PostEra's plan to deepen its use of agentic AI and foundation models for tasks like target validation and mechanistic modeling, areas that could reshape how drug candidates are identified. Its mix of internal pipelines and pharma partnerships suggests the company is trying to prove AI-driven discovery can scale commercially while also serving public-health goals through pandemic-preparedness funding.
- PostEra is actively recruiting AI researchers to grow its agentic drug-discovery research vertical.
- The company has over $1B in AI partnerships, including deals with Pfizer and Amgen.
- PostEra also runs an NIH-funded antiviral discovery center alongside its women's health and fertility pipeline.
Source: jobs.lever.co, 2026-10-13
Published there as: “PostEra (YC W20) Is Hiring AI Researchers for Drug Discovery”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.